Erik LaChapelle

454 total citations
9 papers, 116 citations indexed

About

Erik LaChapelle is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Erik LaChapelle has authored 9 papers receiving a total of 116 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Erik LaChapelle's work include Synthesis and Catalytic Reactions (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Erik LaChapelle is often cited by papers focused on Synthesis and Catalytic Reactions (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Erik LaChapelle collaborates with scholars based in United States. Erik LaChapelle's co-authors include Christopher J. Helal, Rouba Kozak, Rebecca E. O’Connor, Michael A. Brodney, Kelly R. Bales, R. Scott Obach, Christine C. Orozco, Jennifer E. Davoren, James M. Duerr and Martin Pettersson and has published in prestigious journals such as PLoS ONE, Nature Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Erik LaChapelle

9 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik LaChapelle United States	6	53	48	25	12	10	9	116
Kevin J. Hodgetts United States	9	132 2.5×	50 1.0×	25 1.0×	12 1.0×	5 0.5×	13	196
Anna Aparicio United States	7	59 1.1×	42 0.9×	15 0.6×	4 0.3×	10 1.0×	8	94
Mathew M. Mulhern United States	9	111 2.1×	83 1.7×	21 0.8×	19 1.6×	14 1.4×	9	248
Iain Cumming United Kingdom	5	87 1.6×	71 1.5×	33 1.3×	4 0.3×	11 1.1×	6	150
Giorgio Bonanomi Italy	6	61 1.2×	63 1.3×	33 1.3×	4 0.3×	16 1.6×	9	115
Warren J. Porter United States	9	83 1.6×	53 1.1×	33 1.3×	7 0.6×	7 0.7×	13	149
Jill Nunez Switzerland	6	114 2.2×	82 1.7×	15 0.6×	4 0.3×	14 1.4×	6	201
Keith P. Moore United States	8	125 2.4×	51 1.1×	19 0.8×	9 0.8×	20 2.0×	10	190
Michael F. Parker United States	6	28 0.5×	35 0.7×	16 0.6×	6 0.5×	17 1.7×	12	94
Shawn Cabral United States	7	70 1.3×	82 1.7×	13 0.5×	16 1.3×	6 0.6×	12	151

Countries citing papers authored by Erik LaChapelle

Since Specialization

Citations

This map shows the geographic impact of Erik LaChapelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik LaChapelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik LaChapelle more than expected).

Fields of papers citing papers by Erik LaChapelle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik LaChapelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik LaChapelle. The network helps show where Erik LaChapelle may publish in the future.

Co-authorship network of co-authors of Erik LaChapelle

This figure shows the co-authorship network connecting the top 25 collaborators of Erik LaChapelle. A scholar is included among the top collaborators of Erik LaChapelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik LaChapelle. Erik LaChapelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Bi, Cheng, Yu Kawamata, Lauren N. Grant, et al.. (2024). Discovery of N–X anomeric amides as electrophilic halogenation reagents. Nature Chemistry. 16(9). 1539–1545. 22 indexed citations

Dutra, Jason K., Timothy L. Foley, Zhen Huang, et al.. (2021). Fluorophosphonates on‐Demand: A General and Simplified Approach toward Fluorophosphonate Synthesis. ChemBioChem. 22(10). 1769–1774. 5 indexed citations

Bai, Guoyun, Thomas N. O’Connell, Michael A. Brodney, et al.. (2021). Intramolecular Ring-Opening Decomposition of Aryl Azetidines. ACS Medicinal Chemistry Letters. 12(10). 1585–1588. 2 indexed citations

Yang, Qingyi, Erik LaChapelle, Natasha M. Kablaoui, et al.. (2019). Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres. ACS Medicinal Chemistry Letters. 10(6). 941–948. 9 indexed citations

Dresselhaus, Erica C., James M. Duerr, Fabien Vincent, et al.. (2018). Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion. PLoS ONE. 13(3). e0194661–e0194661. 16 indexed citations

Davoren, Jennifer E., Deane M. Nason, Jotham W. Coe, et al.. (2018). Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization. Journal of Medicinal Chemistry. 61(24). 11384–11397. 38 indexed citations

Obach, R. Scott, Erik LaChapelle, Michael A. Brodney, et al.. (2016). Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres. Xenobiotica. 46(12). 1112–1121. 9 indexed citations

Lira, Ricardo, Jason K. Dutra, Kevin Ogilvie, et al.. (2013). Stereoselective Synthesis of Spiropiperidines as BACE-1 Aspartyl Protease Inhibitors via Late Stage N-Arylation of a 1,8-Diazaspiro[4.5]dec-3-en-2-one Pharmacophore. The Journal of Organic Chemistry. 78(6). 2661–2669. 14 indexed citations

Ramaswamy, Gayathri, Mercedes Beyna, James M. Duerr, et al.. (2013). P4–335: A novel LXRα‐ or RX‐independent mechanism for increasing brain APOE levels. Alzheimer s & Dementia. 9(4S_Part_22). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact